Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases

Primary tabs

Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases

Mon, 2024-10-14 10:59 — mike kraft

WHO approves Bavarian Nordic's mpox vaccine for adolescents The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the disease that has triggered global concern. Reuters Reuters

ALSO SEE: Zimbabwe reports first two mpox cases of unspecified variant

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

Africa Resilience Initiative

Medical - global

Vaccines

- Private group -

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Comment	Operations
			No state	No state

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases

Primary tabs

Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases

User login

Search form

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases

Primary tabs

Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases